| 156 | 9 | 22 |
| 下载次数 | 被引频次 | 阅读次数 |
目的系统评价抗生素联合热毒宁治疗儿童社区获得性肺炎的临床研究。方法采用Cochrane系统评价方法,检索万方、维普、中国期刊全文、中国生物医学文献和Pubmed、Embase等中英文数据库,同时手工检索相关资料和网络信息,对纳入的资料进行Meta分析。结果最终纳入8篇研究,共2 451例患者。Meta分析结果显示:与单用抗生素组相比,联合用药组在总有效率(OR=4.83,95%CI[2.9,6.62],P<0.000 01)、退热时间(WMD=-1.61,95%CI[-2.13,-1.08],P<0.000 01)、缩短住院时间(WMD=-1.84,95%CI[-2.12,-1.57],P<0.000 01),不良反应发生率(OR=1.35,95%CI[0.72,2.54],P=0.36)等方面更具优势,差异有统计学意义。结论当前证据显示,抗生素联合热毒宁治疗儿童社区获得性肺炎具有一定优势,但研究存在偏倚的可能性,结论尚需更多高质量的多中心、大样本的随机双盲对照试验加以验证。
Abstract:Objective To systematically evaluate the clinical study of antibiotics combined with Reduning in the treatment of children with community acquired pneumonia. Methods Cochrane systematic evaluation was used to retrieve the related literatures from database such as WanFang,VIP, CNKI, CBM, Pubmed, EMBASE and other Chinese and English databases. Finally, meta-analysis was performed on the included data. Results A total of 8 clinical RCTs involving 2 451 patients were included after exclusion. Meta-analysis showed that, compared with the control group, the test group had obvious advantages in the total effective rate(OR=4.83,95%CI[2.9,6.62],P<0.000 01), the antifebrile time(OR=4.83, 95%CI [2.9, 6.62], P<0.000 01), Shortening the hospital stay(WMD=-1.84,95%CI[-2.12,-1.57],P<0.000 01), the incidence of adverse reactions(OR=1.35,95%CI[0.72,2.54],P=0.36), and other aspects, with statistical difference being significant. Conclusion Current evidence suggests that antibiotics combined with Reduning in the treatment of children with community acquired pneumonia, has certain advantages. However, due to the possibility of bias in the study, So much more high-quality multicenter, large sample, randomized, double-blind, controlled trials were required to verify the conclusion drew here.
[1] 中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童社区获得性肺炎管理指南(2013修订)(上)[J].中华儿科杂志,2013,51(10):745.
[2] 马美琼.儿童社区获得性肺炎的病原学调查及耐药分析[J].中国医药指南,2016,14(8):38-39.
[3] 康丹瑜,耿婷,丁岗,等.热毒宁注射液临床联用及药物相互作用的研究进展[J].中国药房,2017,28(2):276-279.
[4] 潘莲弟.社区获得性肺炎病原菌对头孢类药物耐药性的分析[J].西北药学杂志,2010,25(3):217-218.
[5] 余学庆,谢洋,李建生.社区获得性肺炎中医诊疗指南(2018修订版)[J].中医杂志,2019,60(4):150-159.
[6] 中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童社区获得性肺炎管理指南(2013修订)(下)[J].中华儿科杂志,2013,51(11):856-862.
[7] 赵先,宁泽琼,王婧雯,等.瓜蒌皮注射液治疗心绞痛安全性和有效性的Meta分析[J].西北药学杂志,2016,31(1):86-91.
[8] 陈欣华,陈草明,陈毓强.热毒宁联合头孢呋辛钠治疗儿童社区获得性肺炎120例临床观察[J].成都医学院学报,2009,4(2):117-119.
[9] 周双丽,白明伟.热毒宁联合阿奇霉素治疗儿童社区获得性肺炎[J].中国实用医刊,2011,38(20):101-102.
[10] 潘文桥.中西药联合治疗儿童社区获得性肺炎70例[J].中国中医药现代远程教育,2011,9(21):117-118.
[11] 张寅娥.热毒宁注射液联合阿奇霉素静脉滴注治疗儿童社区获得性肺炎疗效观察[J].中国误诊学杂志,2012,12(16):4304-4305.
[12] 邓文学.热毒宁治疗儿童社区获得性肺炎的效果观察[J].中国临床新医学,2013,6(4):342-345.
[13] 班洪芳,孙清.热毒宁佐治儿童社区获得性肺炎疗效观察[J].中外女性健康(下半月),2014(12):310-315.
[14] 陈勇,蒋宇桐,杨慧敏.热毒宁治疗儿童社区获得性肺炎的随机对照双盲试验研究[J].云南中医学院学报,2015,38(4):73-77.
[15] 刘东凯,刘炜,安晓霞.头孢西丁钠联合热毒宁注射液治疗儿童获得性肺炎对照研究[J].临床心身疾病杂志,2018,24(2):127-130.
[16] 方万芬,刘子龙,赵磊.热毒宁与利巴韦林治疗急性上呼吸道感染患儿的临床疗效比较[J].中华医院感染学杂志,2015,25(15):3572-3574.
[17] 万亚娟,孙建强.热毒宁注射液治疗毛细支气管炎的疗效及对炎症因子水平的影响[J].现代中西医结合杂志,2015,24(14):1535-1537.
[18] 蓝丹,檀卫平,陈环,等.热毒宁对RSV 感染人支气管上皮细胞分泌TSLP的影响[J].中山大学学报,2011,32(2):204-207.
基本信息:
中图分类号:R725.6
引用信息:
[1]李国英,陈良,刘军.抗生素联合热毒宁治疗儿童社区获得性肺炎的系统评价和Meta分析[J].新疆医科大学学报,2020,43(03):349-353+359.
基金信息:
国家自然科学基金(81460603);; 新疆地产中药民族药新药研发培育项目(2017-02-08);; 新疆医科大学科研创新基金(XYDCX201647)
2019-08-15
2019
2019-11-27
2019
1
2020-03-15
2020-03-15